Schütznerová Eva, Oliver Allen G, Slough Greg A, Krchňák Viktor
Institute of Molecular and Translation Medicine, Hněvotínská 5, Olomouc, 779 00, Czech Republic.
Department of Organic Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA.
Chemistry. 2017 Sep 18;23(52):12876-12885. doi: 10.1002/chem.201702461. Epub 2017 Aug 16.
Natural products comprising chiral molecular scaffolds containing fused medium-sized cycles and macrocycles represent an important and relevant pharmacological target for the discovery and development of new drugs. Here, we describe traceless solid-phase synthesis of acyclic intermediates amenable to cyclization to medium (11) and large (12) fused rings. The key aspect of the synthetic strategy is incorporation of a specific conformation constraint that facilitates cyclization in favor of 11- and 12-membered rings rather than possible 7-membered ones. The role of constraints in preorganization required for cyclization is supported by computational analysis. The synthesis involves cyclic N-sulfonyliminium-nucleophilic addition chemistry as the key ring-forming reaction and proceeds with complete stereocontrol of the newly formed stereogenic center. We document the scope and limitations of this strategy in the synthesis of 11+5, 11+6, 11+7, and 12+6 fused rings representing molecular scaffolds with 3D architecture that mimic complex natural products.
包含含有稠合中型环和大环的手性分子骨架的天然产物,是新药发现和开发的重要且相关的药理学靶点。在此,我们描述了可进行环化反应生成中等大小(11元)和大尺寸(12元)稠合环的无环中间体的无痕固相合成方法。该合成策略的关键在于引入特定的构象限制,这有利于环化反应生成11元和12元环,而非可能的7元环。计算分析支持了限制条件在环化所需预组织中的作用。该合成涉及环状N-磺酰基亚胺鎓-亲核加成化学作为关键的成环反应,并对新形成的立体中心进行完全的立体控制。我们记录了该策略在合成11 + 5、11 + 6、11 + 7和12 + 6稠合环中的适用范围和局限性,这些稠合环代表了具有三维结构、模拟复杂天然产物的分子骨架。